Trial Profile
Open-label, Non-randomized, Weekly-dose Titration Study to Assess the Tolerability to HS-20004 in Type 2 (Diabetes Mellitus) Diabetic Patients
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 05 Apr 2018
Price :
$35
*
At a glance
- Drugs HS 20004 (Primary)
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions
- Sponsors Jiangsu Hansoh Pharmaceutical
- 28 Apr 2016 New trial record